[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370505-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370505-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transferrin-receptor-promotes-endometrial-cancer-proliferation-by-activating-the-iron-dependent-pi3kaktmtor-signaling-pathway","Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron-Dependent PI3K/AKT/mTOR Signaling Pathway","","Aberrant iron metabolism is frequently observed in cancers, including endometrial cancer (EC), yet the role of the transferrin receptor (TFRC) in EC remains unclear. TFRC expression is significantly elevated in EC tissues versus adjacent non-tumor tissues and correlates with poor prognosis. TFRC knockdown reduces EC cell proliferation both in vitro and in vivo, whereas TFRC overexpression enhances proliferation. Mechanistically, TFRC activates the iron-dependent PI3K/AKT/mTOR pathway, reversed by rapamycin and rescued by modulating the labile iron pool using FAC or DFO. AURKA is identified as a regulator of TFRC expression, supporting TFRC as a potential prognostic biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transferrin-receptor-promotes-endometrial-cancer-proliferation-by-activating-the-iron-dependent-pi3kaktmtor-signaling-pathway/370505/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transferrin-receptor-promotes-endometrial-cancer-proliferation-by-activating-the-iron-dependent-pi3kaktmtor-signaling-pathway/370505.png","ImageObject",300,407,{"name":42,"@type":43},"\tCallum ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is TFRC related to endometrial cancer outcomes?","Question",{"text":63,"@type":64},"TFRC expression is upregulated in endometrial cancer tissues compared with adjacent non-tumor tissues. Higher TFRC levels are associated with poor prognosis and worse overall survival.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What happens to EC cell proliferation when TFRC is manipulated?",{"text":68,"@type":64},"TFRC knockdown impairs endometrial cancer cell proliferation in vitro and in vivo. In contrast, TFRC overexpression enhances proliferation.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism connects TFRC to proliferation in EC?",{"text":72,"@type":64},"TFRC activates the iron-dependent PI3K/AKT/mTOR signaling pathway. TFRC knockdown suppresses the pathway, rapamycin (an mTOR inhibitor) reverses TFRC-induced pathway activation and proliferation, and iron pool modulation by FAC or DFO rescues TFRC effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370505,1790782836,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nTransferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron-Dependent PI3K/AKT/ mTOR Signaling Pathway  \nYufei Yang1,2  | Ying Ning3 | Yu Chen1,2 | Tian Tian2 | Xinyan Gao1,2 | Yan Kong2 | Ke Lei3 | Zhumei Cui2  \n1Department of Clinical Medicine, Qingdao University, Qingdao, China | 2Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China | 3Center of Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China  \nCorrespondence: Ke Lei ([leike@qdu.edu.cn](leike@qdu.edu.cn)) | Zhumei Cui ([cuizhumei1966@qdu.edu.cn](cuizhumei1966@qdu.edu.cn))  \nReceived: 8 December 2024 | Revised: 22 January 2025 | Accepted: 29 January 2025  \nFunding: This work was supported by National Natural Science Foundation of China (82472719) .  \nKeywords: endometrial cancer | iron metabolism | PI3K/AKT/mTOR signaling pathway | rapamycin | TFRC  \nABSTRACT  \nAberrant iron metabolism is frequently observed in cancers, including endometrial cancer (EC) . However, the role of transferrin receptor (TFRC), a key regulator of iron metabolism, remains unclear in endometrial cancer. We found transferrin receptor expression was significantly upregulated in endometrial cancer tissues compared to adjacent nontumor tissues, and high transferrin receptor levels were associated with poor prognosis. Functional studies revealed that transferrin receptor knockdown impaired endometrial cancer cell proliferation in vitro and in vivo, while transferrin receptor overexpression enhanced endometrial cancer cell proliferation. Mechanistically, transferrin receptor activated the PI3K/AKT/mTOR signaling pathway, as its knockdown suppressed the pathway, and rapamycin, an mTOR inhibitor, reversed transferrin receptor-induced pathway activation and proliferation. Modulation of the labile iron pool by ferric ammonium citrate (FAC) or deferoxamine (DFO) rescued transferrin receptor-induced biological effects. Additionally, AURKA was identified as a regulator of transferrin receptor expression. These findings demonstrate the oncogenic role of transferrin receptor in endometrial cancer and suggest that targeting iron homeostasis and the PI3K/AKT/mTOR pathway may represent potential therapeutic strategies for endometrial cancer.  \n1 | Introduction  \nEndometrial cancer is a prevalent malignant tumor that occurs in the female reproductive system [1, 2] . Although most of patients with localized endometrial cancer have a survival rate exceeding 95%[3, 4], approximately 17% of women present with regional tumor spread at the time of diagnosis (International Federation of Gynecology and Obstetrics (FIGO) stage III) and 9% exhibit distant metastases (FIGO stage IV) [5] . Patients with stage III and IV disease have 5-year survival rates of  \n48% and 15%[6] . Due to the lack of effective treatments for advanced-stage, targeted therapies are emerging as innovative and promising treatment strategies. Therefore, there is an urgent need to identify novel prognostic biomarkers and explore new therapeutic strategies to enhance the clinical outcomes of EC patients.  \nIron plays a pivotal role in multiple metabolic and physiological processes [7] . Studies suggest that aberrant iron metabolism is closely associated with tumorigenesis and tumor progression  \n\n| Abbreviations: DFO, deferoxamine mesylate; EC, endometrial cancer; FAC, ferric ammonium citrate; IHC, immunohistochemistry; ORR, overall response rate; OS, overall survival; PFS, progression-free survival; RAPA, rapamycin; TCGA, The Cancer Genome Atlas; TFRC, transferrin receptor; UCEC, uterine corpus endometrial carcinoma. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial an","cbCaim4KORPx5icB","https://ap.wps.com/l/cbCaim4KORPx5icB","pdf",7941865,14,"English","# Abstract\n# Introduction\n# Material and Methods","[{\"question\":\"How is TFRC related to endometrial cancer outcomes?\",\"answer\":\"TFRC expression is upregulated in endometrial cancer tissues compared with adjacent non-tumor tissues. Higher TFRC levels are associated with poor prognosis and worse overall survival.\"},{\"question\":\"What happens to EC cell proliferation when TFRC is manipulated?\",\"answer\":\"TFRC knockdown impairs endometrial cancer cell proliferation in vitro and in vivo. In contrast, TFRC overexpression enhances proliferation.\"},{\"question\":\"What mechanism connects TFRC to proliferation in EC?\",\"answer\":\"TFRC activates the iron-dependent PI3K/AKT/mTOR signaling pathway. TFRC knockdown suppresses the pathway, rapamycin (an mTOR inhibitor) reverses TFRC-induced pathway activation and proliferation, and iron pool modulation by FAC or DFO rescues TFRC effects.\"}]","Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron-Dependent PI3K/AKT/mTOR Signaling Pathway | PDF",1790188874,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd3e89ad94ade76d1308aeb9d480d461.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4766db0ab301c20e231516d71562bf9d.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a95521f17d05cf56d38e2d0e1557ebb2.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08b3d135e5e00fccaffed28ce68864f0.webp",980,1287]